OrthoPediatrics Launches New Division for Digital Health Advancements

OrthoPediatrics Unveils Enabling Technologies Division

OrthoPediatrics Corp. (NASDAQ: KIDS), a robust player in pediatric orthopedics, has taken a significant step forward by launching its Enabling Technologies division. This initiative not only aligns with the company’s mission of meeting the diverse needs in pediatric orthopedics, but also expands its reach into the burgeoning fields of digital health and advanced technology. With Kevin Unger, an industry veteran at the helm, this new division promises to transform the way OrthoPediatrics operates and grows, strengthening its core business while exploring new avenues for revenue generation.

Building on Existing Innovations

OrthoPediatrics has already established itself as a leader by distributing the 7D Flash™ Navigation System and forming a partnership with 3D Side, S.A. to create patient-specific cutting guides. These pioneering efforts have set a solid groundwork for the emerging Enabling Technologies division. The company is now preparing to launch two innovative technology platforms that are expected to redefine standards in the medical field.

Introducing Playbook

The first platform, Playbook, is envisioned as a revolutionary surgical workflow and outcome optimization tool. This cutting-edge platform focuses on enhancing surgical planning, facilitating collaboration among medical teams, and improving intraoperative workflow. By streamlining these processes, Playbook aims to elevate the success rates of surgeries and optimize patient outcomes, heralding a new era in surgical efficiency.

Robotic Assistance in Surgery

In tandem with the introduction of Playbook, OrthoPediatrics is also launching a robotic-assisted technology designed specifically for cochlear implant surgeries. Collaborating with iotaMotion, Inc., this innovative solution aims to deliver a more controlled and precise insertion of electrode arrays during surgery. This system is engineered to be compatible with any cochlear implant manufacturer, thereby enhancing its versatility and effectiveness for pediatric patients.

CEO’s Vision and Commitment

David Bailey, the CEO of OrthoPediatrics, expressed his enthusiasm regarding the launch of the Enabling Technologies division. He stated, "We are thrilled to introduce the new Enabling Technologies division, which will help us expand our ability to positively impact more children and provide significant long-term growth opportunities. This marks an exciting step forward in our commitment to innovation and helping kids. We believe these advancements will not only support our mission to improve pediatric care but also position us at the forefront of the pediatric digital health and enabling technologies sectors."

Upcoming Investor Day

Adding to the momentum, OrthoPediatrics will host an investor day at 10:30 am E.T., offering insights into the company's future directions and growth strategies. This event will also feature a live webcast, providing an opportunity for stakeholders and potential investors to engage with the company’s vision directly.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is solely dedicated to the advancement of pediatric orthopedics. With a comprehensive product portfolio exceeding 70 items catering to major categories such as trauma, deformity correction, scoliosis, and sports medicine, the company is positioned as a leader in the market. Serving not only the United States but also over 70 countries globally, OrthoPediatrics continues to focus on improving the lives of children suffering from orthopedic conditions.

Contact Information

For more inquiries, you can reach Out to:
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

Frequently Asked Questions

What is the focus of OrthoPediatrics' new division?

The Enabling Technologies division focuses on enhancing pediatric healthcare through innovations in digital health and advanced technologies.

How will Playbook improve surgical outcomes?

Playbook aims to streamline surgical workflow and enhance collaboration among medical professionals, resulting in more precise surgeries and better patient outcomes.

What unique feature does the robotic assistance for cochlear implants offer?

It allows for slow electrode array insertion that can work with any cochlear implant manufacturer, providing greater control during surgery.

When will the investor day event take place?

The investor day is scheduled for 10:30 am E.T., and it will also be available as a live webcast.

How long has OrthoPediatrics been operating?

OrthoPediatrics was founded in 2006, focusing exclusively on pediatric orthopedic advancements.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.